Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma

NY-ESO-1 is a cancer-testis antigen aberrantly expressed in melanomas, which may serve as a robust and specific target in immunotherapy. NY-ESO-1 antigen expression, tumor features, and the immune profile of tumor infiltrating lymphocytes were assessed in primary cutaneous melanoma. NY-ESO-1 protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Giavina-Bianchi, Mara, Giavina-Bianchi, Pedro, Sotto, Mirian Nacagami, Muzikansky, Alona, Kalil, Jorge, Festa-Neto, Cyro, Duncan, Lyn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411457/
https://www.ncbi.nlm.nih.gov/pubmed/25954764
http://dx.doi.org/10.1155/2015/761378

Ejemplares similares

Ejemplares similares